Topical dinitrochlorobenzene (DNCB) for alopecia areata: Revisited.

1. Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41:401-7. 2. Reed WB, Becker SW, Rhode, Heiskell CL. Psoriasis and arthritis: A clinicopathological study. Arch Dermatol 1961;83:541-8. 3. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296:1735-41. 4. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978;99:469-75. 5. McDonald CJ. Cardiovascular complications of psoriasis. In: Roenigk HH, Maibach HI, editors. Psoriasis. 2 nd ed. New York: Marcel Dekker Inc; 1991. p. 97-111. 6. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavourable cardiovascular risk profiles in treated and untreated psoriasis patients. Atherosclerosis 2007;190:1-9. 7. Ludwig RJ, Schultz JE, Boekncke WH, Podda M, Tandi C, Krombach F, et al. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 2004;122:830-6. 8. Malerba M, Gisondi P, Radaeli A, Sala R, Calzavara Pinton PG, Girolomoni G. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 2006;155:1165-9.